Society for Endocrinology - a world-leading authority on hormones

Call to 'suspend' diabetes drug (BBC News, 23 September 2010)

23 Sept 2010


The European Medicines Agency has recommended that marketing authorisation for the diabetes drug Avandia (generic name rosiglitazone) be suspended following a review of data on the drug's cardiovascular side-effects.

Full article